O'loughlin Steve Insider Trades

Insider Trading History

Track insider trading activity for O'loughlin Steve. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $50.2k 9,500 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.7k 9,500 shares
$3.13
$5.28
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.37k 3,333 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$14.2k 8,833 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.5k 13,333 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$173k 107,463 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$95.1k 59,066 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$408k 253,123 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.37k 3,333 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$413k 256,438 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.68k 1,666 shares
$1.61
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $281k 253,123 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 253,123 shares
$5.00
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $285k 256,348 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 256,438 shares
$4.96
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $119k 107,463 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$652k 107,463 shares
$6.07
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Financial Officer
Holding Value $65.6k 59,066 shares
Last Trade
Aug 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$564k 59,066 shares
$9.55
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $444k 400,000 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 400,000 shares
$6.96
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $39.4k 35,500 shares
Last Trade
Dec 10, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$130k 10,000 shares
$13.00
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $294k 265,000 shares
Last Trade
Jul 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.22M 265,000 shares
$23.49
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $28.3k 25,500 shares
Last Trade
Jun 15, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$180k 12,000 shares
$15.00
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $15k 13,500 shares
Last Trade
Mar 06, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$261k 20,000 shares
$13.05
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Principal Financial Officer
Holding Value $3.89k 3,500 shares
Last Trade
Jun 15, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$121k 3,500 shares
$34.50
$1.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up